|
Name |
3,5-Di-tert-butyl-o-benzoquinone
|
Molecular Formula | C14H20O2 | |
IUPAC Name* |
3,5-ditert-butylcyclohexa-3,5-diene-1,2-dione
|
|
SMILES |
CC(C)(C)C1=CC(=O)C(=O)C(=C1)C(C)(C)C
|
|
InChI |
InChI=1S/C14H20O2/c1-13(2,3)9-7-10(14(4,5)6)12(16)11(15)8-9/h7-8H,1-6H3
|
|
InChIKey |
NOUZOVBGCDDMSX-UHFFFAOYSA-N
|
|
Synonyms |
3,5-Di-tert-butyl-o-benzoquinone; 3383-21-9; 3,5-Di-tert-butyl-1,2-benzoquinone; 3,5-di(tert-butyl)benzo-1,2-quinone; 3,5-Cyclohexadiene-1,2-dione, 3,5-bis(1,1-dimethylethyl)-; 3,5-di-tert-butylbenzo-1,2-quinone; 3,5-di-tert-butylcyclohexa-3,5-diene-1,2-dione; o-Benzoquinone, 3,5-di-tert-butyl-; 3,5-ditert-butylcyclohexa-3,5-diene-1,2-dione; 3,5-Di-tert-butyl-o-quinone; 3,5-di-t-Butyl-o-benzoquinone; 3,5-di-t-butyl-1,2-benzoquinone; 3,5-Ditert-butylbenzo-1,2-quinone; EINECS 222-189-0; MFCD00001647; NSC 149061; 3,5-Ditert-butyl-quinone; cid_76915; MLS000699499; SCHEMBL396841; CHEMBL365161; BDBM22775; DTXSID70187478; o-Benzoquinone,5-di-tert-butyl-; HMS2618F24; 3,5-di-t-butyl-1,2-dioxobenzene; ALBB-029895; ZINC1734421; NSC149061; 3,5-ditert-butyl-[1,2]benzoquinone; 3,5-di-tert-Butyl-ortho-benzoquinone; AKOS001667084; NSC-149061; 3,5-Ditert-butylbenzo-1,2-quinone #; NCGC00247199-01; 3,5-Di-tert-butyl-o-benzoquinone, 98%; AS-60966; SMR000226412; 3,2-dione, 3,5-bis(1,1-dimethylethyl)-; CS-0095759; D2430; FT-0614738; 3,5-Bis(tert-butyl)-1,2-benzoquinone 98%; D86498; AH-188/25003063; J-511242
|
|
CAS | 3383-21-9 | |
PubChem CID | 76915 | |
ChEMBL ID | CHEMBL365161 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 220.31 | ALogp: | 3.3 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 34.1 | Aromatic Rings: | 1 |
Heavy Atoms: | 16 | QED Weighted: | 0.458 |
Caco-2 Permeability: | -4.832 | MDCK Permeability: | 0.00001580 |
Pgp-inhibitor: | 0.995 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.014 | 20% Bioavailability (F20%): | 0.435 |
30% Bioavailability (F30%): | 0.042 |
Blood-Brain-Barrier Penetration (BBB): | 0.012 | Plasma Protein Binding (PPB): | 94.17% |
Volume Distribution (VD): | 1.818 | Fu: | 6.99% |
CYP1A2-inhibitor: | 0.92 | CYP1A2-substrate: | 0.953 |
CYP2C19-inhibitor: | 0.917 | CYP2C19-substrate: | 0.845 |
CYP2C9-inhibitor: | 0.803 | CYP2C9-substrate: | 0.798 |
CYP2D6-inhibitor: | 0.706 | CYP2D6-substrate: | 0.274 |
CYP3A4-inhibitor: | 0.274 | CYP3A4-substrate: | 0.386 |
Clearance (CL): | 3.51 | Half-life (T1/2): | 0.334 |
hERG Blockers: | 0.012 | Human Hepatotoxicity (H-HT): | 0.209 |
Drug-inuced Liver Injury (DILI): | 0.244 | AMES Toxicity: | 0.104 |
Rat Oral Acute Toxicity: | 0.629 | Maximum Recommended Daily Dose: | 0.839 |
Skin Sensitization: | 0.906 | Carcinogencity: | 0.794 |
Eye Corrosion: | 0.947 | Eye Irritation: | 0.96 |
Respiratory Toxicity: | 0.55 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000452 | 0.667 | D0W7WC | 0.269 | ||||
ENC000513 | 0.633 | D01JFT | 0.250 | ||||
ENC000811 | 0.566 | D03GET | 0.226 | ||||
ENC001383 | 0.481 | D0Y4DY | 0.219 | ||||
ENC001233 | 0.460 | D06YPU | 0.215 | ||||
ENC000708 | 0.383 | D00NJL | 0.209 | ||||
ENC000610 | 0.379 | D0H2DQ | 0.206 | ||||
ENC000079 | 0.379 | D09EBS | 0.197 | ||||
ENC000346 | 0.379 | D0ML1F | 0.189 | ||||
ENC000725 | 0.379 | D0X4ZR | 0.188 |